These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34509358)

  • 21. Acute effects of dietary phosphorus intake on markers of mineral metabolism in hemodialysis patients: post hoc analysis of a randomized crossover trial.
    Tsai WC; Wu HY; Chiu YL; Yang JY; Pai MF; Wu YR; Lin WY; Hung KY; Chien KL; Hsu SP; Peng YS
    Ren Fail; 2021 Dec; 43(1):141-148. PubMed ID: 33427559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.
    Desjardins L; Liabeuf S; Renard C; Lenglet A; Lemke HD; Choukroun G; Drueke TB; Massy ZA;
    Osteoporos Int; 2012 Jul; 23(7):2017-25. PubMed ID: 22109743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Plant-Based Protein Consumption on Kidney Function and Mineral Bone Disorder Outcomes in Adults With Stage 3-5 Chronic Kidney Disease: A Systematic Review.
    Burstad KM; Cladis DP; Wiese GN; Butler M; Hill Gallant KM
    J Ren Nutr; 2023 Nov; 33(6):717-730. PubMed ID: 37116624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of oral sodium bicarbonate supplementation in maintaining acid-base balance and its influence on the cardiovascular system in chronic hemodialysis patients - results of a prospective study.
    Voiculeț C; Zară O; Bogeanu C; Văcăroiu I; Aron G
    J Med Life; 2016; 9(4):449-454. PubMed ID: 27928454
    [No Abstract]   [Full Text] [Related]  

  • 25. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
    Molony DA; Stephens BW
    Adv Chronic Kidney Dis; 2011 Mar; 18(2):120-31. PubMed ID: 21406297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study.
    Ix JH; Anderson CA; Smits G; Persky MS; Block GA
    Am J Clin Nutr; 2014 Nov; 100(5):1392-7. PubMed ID: 25332338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary Phosphate Consumption in Australians With Stages 3b and 4 Chronic Kidney Disease.
    Conley M; Lioufas N; Toussaint ND; Elder GJ; Badve SV; Hawley CM; Pascoe EM; Pedagogos E; Valks A; Campbell KL
    J Ren Nutr; 2021 Mar; 31(2):155-163. PubMed ID: 32466982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium, phosphate and parathyroid metabolism in kidney transplanted patients.
    Ambrus C; Molnar MZ; Czira ME; Rosivall L; Kiss I; Remport A; Szathmari M; Mucsi I
    Int Urol Nephrol; 2009 Dec; 41(4):1029-38. PubMed ID: 19701690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale.
    Bressendorff I; Hansen D; Schou M; Kragelund C; Brandi L
    BMJ Open; 2017 Jun; 7(6):e016795. PubMed ID: 28645983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daily variability in serum levels of calciprotein particles and their association with mineral metabolism parameters: A cross-sectional pilot study.
    Yamada H; Kuro-O M; Ishikawa SE; Funazaki S; Kusaka I; Kakei M; Hara K
    Nephrology (Carlton); 2018 Mar; 23(3):226-230. PubMed ID: 28052525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease.
    Scialla JJ; Leonard MB; Townsend RR; Appel L; Wolf M; Budoff MJ; Chen J; Lustigova E; Gadegbeku CA; Glenn M; Hanish A; Raj D; Rosas SE; Seliger SL; Weir MR; Parekh RS;
    Clin J Am Soc Nephrol; 2011 Nov; 6(11):2612-9. PubMed ID: 21940840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in FGF-23, Neutrophil/Platelet Activation Markers, and Angiogenin in Advanced Chronic Kidney Disease and Their Effect on Arterial Stiffness.
    Choi HM; Kwon YE; Kim S; Oh DJ
    Kidney Blood Press Res; 2019; 44(5):1166-1178. PubMed ID: 31553973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease.
    Hong YA; Lim JH; Kim MY; Kim Y; Yang KS; Chung BH; Chung S; Choi BS; Yang CW; Kim YS; Chang YS; Park CW
    Clin Exp Nephrol; 2015 Apr; 19(2):208-15. PubMed ID: 24682550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease.
    Chue CD; Edwards NC; Davis LJ; Steeds RP; Townend JN; Ferro CJ
    Nephrol Dial Transplant; 2011 Aug; 26(8):2576-82. PubMed ID: 21248296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes mellitus modifies the association between chronic kidney disease-mineral and bone disorder biomarkers and aortic stiffness in peritoneal dialysis patients.
    Huang HJ; Hsu BG; Wang CH; Tsai JP; Chen YH; Hung SC; Lin YL
    Sci Rep; 2024 Feb; 14(1):4554. PubMed ID: 38402283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: The Modification of Diet in Renal Disease Study.
    Selamet U; Tighiouart H; Sarnak MJ; Beck G; Levey AS; Block G; Ix JH
    Kidney Int; 2016 Jan; 89(1):176-84. PubMed ID: 26422502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease.
    Larivière R; Gauthier-Bastien A; Ung RV; St-Hilaire J; Mac-Way F; Richard DE; Agharazii M
    J Hypertens; 2017 Feb; 35(2):376-384. PubMed ID: 28005706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Novel Bone Alkaline Phosphatase Isoform B1x Is Associated with Improved 5-Year Survival in Chronic Kidney Disease.
    Haarhaus M; Fernström A; Qureshi AR; Magnusson P
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interplay between bone and vessels in pediatric CKD: lessons from a single-center study.
    Preka E; Ranchin B; Doyon A; Vierge M; Ginhoux T; Kassai B; Bacchetta J
    Pediatr Nephrol; 2018 Sep; 33(9):1565-1575. PubMed ID: 29872964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.